ÂÜÀòÂÒÂ×

Erin Montgomery is a finance professional with extensive experience in the pharmaceutical industry and public accounting. Currently serving as the Senior Director of Finance - R&D and Senior Director of Accounting Policy & SOX Compliance at Intra-Cellular Therapies since March 2022, Erin previously held the position of Assurance Senior Manager at EY from October 2013 to March 2022. Erin holds a Master of Business Administration (MBA) degree from San Diego State University, obtained between August 2004 and May 2006.